Zdrowie i gospodarka · 08/11/2017
FDA Announces Guidance for Developing Drugs to Treat and Prevent Recurrent Herpes Labialis
The FDA has released a guidance document to help pharmaceutical companies develop treatments and preventions for recurrent herpes labialis, a condition that affects millions of people worldwide.